Search research articles
Contact Us
Filters
Showing results (31-40 of 114) with videos related to
Page
of 12
Sort By:
European Journal of Haematology
|
February 14, 2004
Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies
Moshe Mittelman, Aliza Zeidman, Pazit Kanter, et al.
The Israel Medical Association Journal : IMAJ
|
November 28, 2006
Erythropoietin in clinical practice: current use, effect on survival, and future directions
Howard S Oster, Michael Hoffman, Sara Prutchi-Sagiv, et al.
Haematologica
|
January 29, 2026
Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker
Ariel Israel, Roi Gat, Howard Oster, et al.
Blood
|
October 18, 2021
Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting
Moshe Mittelman, Ori Magen, Noam Barda, et al.
European Journal of Haematology
|
January 4, 2025
Do we Need to Perform Bone Marrow Examination in all Subjects Suspected of MDS? Evaluation and Validation of Non-Invasive (Web-Based) Diagnostic Algorithm
Howard S Oster, Ariel M Polakow, Roi Gat, et al.
The Israel Medical Association Journal : IMAJ
|
October 17, 2018
Myelodysplastic Syndromes Over Time: A Comparison of Two Patient Cohorts
Howard S Oster, Shani Svorai-Litvak, Ilya Kirgner, et al.
Leukemia Research
|
April 21, 2009
Non-erythroid effects of erythropoietin: are neutrophils a target?
Maayan Avneon, Lilach Lifshitz, Odelia Katz, et al.
European Journal of Immunology
|
April 27, 2007
Erythropoietin enhances immune responses in mice
Odelia Katz, Lidor Gil, Lilach Lifshitz, et al.
Scientific Reports
|
August 3, 2016
Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss
Naamit Deshet-Unger, Sahar Hiram-Bab, Yasmin Haim-Ohana, et al.
Experimental Hematology
|
October 31, 2012
Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patients
Howard S Oster, Sara Prutchi-Sagiv, Ora Halutz, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 114) with videos related to
Sort By:
Page
of 12
European Journal of Haematology
|
February 14, 2004
Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies
Moshe Mittelman, Aliza Zeidman, Pazit Kanter, et al.
The Israel Medical Association Journal : IMAJ
|
November 28, 2006
Erythropoietin in clinical practice: current use, effect on survival, and future directions
Howard S Oster, Michael Hoffman, Sara Prutchi-Sagiv, et al.
Haematologica
|
January 29, 2026
Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker
Ariel Israel, Roi Gat, Howard Oster, et al.
Blood
|
October 18, 2021
Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting
Moshe Mittelman, Ori Magen, Noam Barda, et al.
European Journal of Haematology
|
January 4, 2025
Do we Need to Perform Bone Marrow Examination in all Subjects Suspected of MDS? Evaluation and Validation of Non-Invasive (Web-Based) Diagnostic Algorithm
Howard S Oster, Ariel M Polakow, Roi Gat, et al.
The Israel Medical Association Journal : IMAJ
|
October 17, 2018
Myelodysplastic Syndromes Over Time: A Comparison of Two Patient Cohorts
Howard S Oster, Shani Svorai-Litvak, Ilya Kirgner, et al.
Leukemia Research
|
April 21, 2009
Non-erythroid effects of erythropoietin: are neutrophils a target?
Maayan Avneon, Lilach Lifshitz, Odelia Katz, et al.
European Journal of Immunology
|
April 27, 2007
Erythropoietin enhances immune responses in mice
Odelia Katz, Lidor Gil, Lilach Lifshitz, et al.
Scientific Reports
|
August 3, 2016
Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss
Naamit Deshet-Unger, Sahar Hiram-Bab, Yasmin Haim-Ohana, et al.
Experimental Hematology
|
October 31, 2012
Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patients
Howard S Oster, Sara Prutchi-Sagiv, Ora Halutz, et al.
Page
of 12